Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy.

Minglani VV, Patel MB, Upadhyay TK

DOI: 10.1007/s40199-026-00635-9
Published: 2026 Sep 16
Container: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40199-026-00635-9,
  title = {Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy.},
  author = {Minglani VV and Patel MB and Upadhyay TK},
  year = {2026},
  journal = {Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences},
  doi = {10.1007/s40199-026-00635-9},
  url = {https://doi.org/10.1007/s40199-026-00635-9}
}

RIS

TY  - JOUR
TI  - Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy.
AU  - Minglani VV
AU  - Patel MB
AU  - Upadhyay TK
PY  - 2026
JO  - Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
DO  - 10.1007/s40199-026-00635-9
UR  - https://doi.org/10.1007/s40199-026-00635-9
ER  -

APA

VV, M., MB, P., & TK, U. (2026). Development of nanoemulsion-based in situ gel formulation of escitalopram oxalate for intranasal delivery in depression therapy.. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. https://doi.org/10.1007/s40199-026-00635-9

Source records

pubmed · retrieved 2026-09-25T06:23:26.412Z